Carcinoembryonic antigen and matrix metalloproteinase 2 serum and peritoneal washes concentration in staging and prognosis in colorectal cancer patients

Pol Przegl Chir. 2018 Jun 20;90(5):36-43. doi: 10.5604/01.3001.0012.1269.

Abstract

Purpose: The aim of the study was to determine of carcinoembryonal antigen and matrix metalloproteinase 2 peritoneal washes and serum concentration in patients suffering from colorectal cancer concerning tumor staging and 5-year survival rate in these patients.

Methods: 80 patients who underwent curative surgery for colorectal cancer were included into the study. Preoperative serum and intraoperative peritoneal washes CEA and MMP-2 concentrations were measured.

Results: Concerning tumor penetration CEA-s and CEA-p concentration was higher in subsequent stages from T2 to T4. Both CEA-s and CEA-p concentration was lower in T2 comparing to T3 and T4. Significant difference of CEA-s and CEA-p was noted between T2 and T4 stages. MMP2-s concentration was higher in T3 comparing to T2, the highest MMP2-p concentration was in T4, with no statistical significance. Concerning nodular status significant difference of CEA-s was noted between N0 and N1. For CEA-p significance was found between N0 and N2 as between N1 and N2. MMP2-s concentration was the highest in N1, MMP2-p concentration was the highest in T4, with no statistical significance. 5-year survival rate for all patients was 63,53%. There were significant differences in CEA-s and CEA-p concentration between patients with negative and positive 5-year survival.

Conclusion: Intraoperative peritoneal washes concentration of CEA may potentially serve as an important factor for more precise colorectal cancer staging. CEA-p and CEA-s concentration correlates with survival rate in patients suffering from colorectal cancer and can be useful as an additional prognostic factor. Usefulness of MMP2 measurement still requires further studies.

Keywords: CEA; MMP-2; colorectal cancer; peritoneal washes.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Biomarkers, Tumor / blood*
  • Carcinoembryonic Antigen / blood*
  • Colonic Neoplasms / blood*
  • Colonic Neoplasms / pathology*
  • Colorectal Neoplasms / blood*
  • Colorectal Neoplasms / pathology*
  • Female
  • Humans
  • Male
  • Matrix Metalloproteinase 2 / blood*
  • Middle Aged
  • Neoplasm Staging / methods
  • Peritoneum / chemistry
  • Postoperative Period
  • Preoperative Period
  • Prognosis
  • Survival Rate

Substances

  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Matrix Metalloproteinase 2